Ann H. Partridge, MD, MPH, still remembers her patient’s anger 25 years later.Partridge, founder and director of the Young ...

In this Nourish to Flourish column, Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Nina Crowley, PhD, RDN, LD, about ...

This 94-year-old patient presents with cataracts and pseudoexfoliation syndrome, with the right eye having more stability and ...

A 46-year-old woman with hypothyroidism and prior substance use disorder presented to the emergency department with a 1-week ...

Retatrutide conferred weight loss of greater than 20% for adults with obesity and type 2 diabetes, as well as those with ...

Pain, systemic inflammation and HLA-B27 are the “strongest” predictors for psoriatic arthritis among patients with psoriasis, ...

The FDA has approved zidesamtinib for adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer.Zidesamtinib (Jideytro, GSK) is designed to provide highly selective coverage ...

More than 80% of young adults with advanced cancer do not receive guideline-recommended palliative care along with systemic treatment despite utilization doubling between 2010 and 2023.Patients with ...

The Senate’s Health, Education, Labor and Pensions Committee delayed a scheduled vote Thursday on the nomination of Erica Schwartz, MD, JD, MPH, to be the next CDC director.The vote was scheduled to ...

More people globally are living longer, but many of those extra years are spent experiencing disability and diseases, according to a new report in Lancet Public Health.“The central finding is that we ...

Epioxa obtained FDA approval in October 2025, which makes it the first and only FDA-approved epithelium-on, oxygen-enriched corneal cross-linking treatment for patients with keratoconus. Epioxa ...

Survival for adults with congenital heart disease improved over the past 30 years, but those living in states with lower median household income and more uninsured people had higher rates of death and ...